REVVITY, INC Marketable Securities (Current)
REVVITY, INC (RVTY) had Marketable Securities (Current) of $0 as of 2024-12-29, per its 10-K filed 2025-02-25.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-02-25
- 2024-12-29: Marketable Securities, Current $0.00.
- 2024-09-29: Marketable Securities, Current $0.00.
- 2024-06-30: Marketable Securities, Current $706.07M.
- 2024-03-31: Marketable Securities, Current $697.33M.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-12-29 | $0.00 10-K · filed 2025-02-25 |
| 2024-09-29 | $0.00 10-Q · filed 2024-11-06 |
| 2024-06-30 | $706.07M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $697.33M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $689.92M 10-K · filed 2025-02-25 |
| 2023-10-01 | $292.97M 10-Q · filed 2023-11-07 |
| 2023-07-02 | $739.05M 10-Q · filed 2023-08-09 |
| 2023-04-02 | $193.96M 10-Q · filed 2023-05-12 |
| 2023-01-01 | $0.00 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |